Related Experiment Videos
Insulin-like growth factor-I in children with short stature
Insights
Serum insulin-like growth factor-I (IGF-I) levels aid in diagnosing short stature in children. Low IGF-I levels in prepubertal children strongly indicate growth hormone deficiency, aiding clinical evaluation.
Area of Science:
- Pediatric Endocrinology
- Growth Disorders
- Biochemical Markers
Background:
- Short stature in prepubertal children requires accurate diagnostic methods.
- Serum insulin-like growth factor-I (IGF-I) is a key mediator of growth hormone action.
- Evaluating IGF-I levels can help differentiate causes of short stature.
Purpose of the Study:
- To assess the clinical utility of serum IGF-I measurements in the diagnostic workup of short prepubertal children.
- To determine if IGF-I levels can distinguish between different causes of short stature.
Main Methods:
- Radioimmunoassay was used to measure serum IGF-I levels.
- Study included 92 short prepubertal children (categorized by stature and condition) and 105 normal prepubertal children.
- Comparative analysis of mean serum IGF-I levels across study groups.
Main Results:
- Children with classical growth hormone deficiency exhibited significantly lower mean serum IGF-I levels compared to normal-short and dysmorphic-short children.
- Mean serum IGF-I levels in normal-short and dysmorphic-short children were comparable to those of normal prepubertal children.
- Serum IGF-I levels effectively differentiated classical growth hormone deficiency from other causes of short stature.
Conclusions:
- Serum IGF-I level determination is a valuable tool for evaluating short prepubertal children.
- IGF-I testing aids in the diagnosis of growth hormone deficiency in pediatric short stature.
- This biomarker supports clinical decision-making in pediatric growth assessment.
Abstract:
The purpose of this study was to evaluate the clinical application of serum insulin-like growth factor-I (IGF-I) levels for the workup of prepubertal children with short stature. IGF-I serum levels were measured by radioimmunoassay in 92 short prepubertal children (55 normal-short children, 18 dysmorphic-short children, and 19 children with classical growth hormone deficiency) and 105 normal prepubertal children. The serum IGF-I levels (mean +/- SEM) in these three groups of short children were 160 +/- 9 ng/ml, 188 +/- 16 ng/ml and 26 +/- 3 ng/ml, respectively. The mean serum IGF-I level for the 105 normal prepubertal children was 160 +/- 7 ng/ml. The mean serum IGF-I levels of the first two groups of short children were not significantly different from that of the prepubertal children with normal stature. On the other hand, the mean serum IGF-I level in children with classical growth hormone deficiency was significantly lower than those of the other two groups of short children and that of prepubertal children with normal stature. Our study shows that the determination of serum IGF-I levels is of clinical value in the evaluation of short prepubertal children.